Table 1.
Patients’ characteristics (n = 32)
| Characteristic | Value |
|---|---|
| Age (yr) | 67 (41–81) |
| Sex | |
| Male | 18 |
| Female | 14 |
| ECOG performance status | |
| 0 | 17 |
| 1 | 14 |
| 2 | 1 |
| Postoperative stage | |
| I | 3 |
| II | 6 |
| IIIA | 14 |
| IIIB | 6 |
| IV (liver metastasis) | 3 |
| Time from primary surgery to any failure (mo) | 24 (3–99) |
| Time from primary surgery to local recurrence (mo) | 30 (4–99) |
| Recurrent site | |
| Axial | 11 |
| Anterior | 3 |
| Posterior | 15 |
| Lateral | 3 |
| Metastasis | |
| Regional | 2 |
| Regional and distant | 2 |
| Distant | 10 |
| None | 18 |
| Tumor size (mm) | 39 (12–150) |
| CEA (ng/mL) | 12.7 (1.5–774) |
| Pain | |
| Yes | 22 |
| No | 10 |
| BED (Gy10) | 72.0 (48.0–95.2) |
| ≥75 | 7 |
| <75 | 25 |
| Concurrent chemotherapy | |
| Yes | 20 |
| No | 12 |
| Adjuvant chemotherapy after RT | |
| Yes | 24 |
| No | 8 |
| Follow-up period (mo) | 16 (4–108) |
Values are presented as median (range).
ECOG, Eastern Cooperative Oncology Group; CEA, carcinoembryonic antigen; BED, biological effective dose with α/β = 10 Gy; RT, radiotherapy.